Menu

Brain Prize Laureate Will Donate Some Winnings to Anti-Brexit Group

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.

Mar 6, 2018
Shawna Williams

ISTOCK, ANDREJ_KAt a press conference today (March 6), one of the four winners of this year’s Brain Prize, University College London neuroscientist John Hardy, turned attention to the impact of Britain’s impending exit from the European Union on science and healthcare in the country. The expected exodus of healthcare workers from other European countries will strain the ability of the U.K.’s National Health Service to care for the growing number of patients with dementia, Hardy predicts.

As reported in The Guardian, Hardy shares the €1 million prize with Bart De Strooper, also of University College London; Michel Goedert of the Medical Research Council Laboratory of Molecular Biology in Cambridge, U.K.; and Christian Haass of the Ludwig-Maximilians-University in Munich, for their discoveries on the mechanisms underlying Alzheimer’s disease.

See “Do Microbes Trigger Alzheimer’s Disease?

“When you go around the hospitals, so many of the geriatricians and neurologists are Europeans, and the nurses and carers,” Hardy said during the press conference (via The Guardian). “As a society we’re not doing very well, and the indications are we’re going to do even worse.” The BBC reports that he plans to donate about €5,000 to groups striving to keep Britain in the E.U.

Hardy is far from the first to predict dire consequences of Brexit for health and science. Ahead of the 2016 referendum on whether to remain in the E.U., for example, Nature found that 83 percent of researchers favored staying.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!